CRAMPEX TABLETS

Maa: Irlanti

Kieli: englanti

Lähde: HPRA (Health Products Regulatory Authority)

Osta se nyt

Lataa Pakkausseloste (PIL)
12-06-2015
Lataa Valmisteyhteenveto (SPC)
29-07-2016

Aktiivinen ainesosa:

COLECALCIFEROL ; CALCIUM CARBONATE ; NICOTINIC ACID

Saatavilla:

Thornton & Ross Limited

ATC-koodi:

A12AX

INN (Kansainvälinen yleisnimi):

COLECALCIFEROL ; CALCIUM CARBONATE ; NICOTINIC ACID

Annos:

%v/v

Lääkemuoto:

Tablets

Prescription tyyppi:

Product not subject to medical prescription

Terapeuttinen alue:

Calcium, combinations with vitamin D and/or other drugs

Valtuutuksen tilan:

Marketed

Valtuutus päivämäärä:

1993-04-23

Pakkausseloste

                                PACKAGE LEAFLET: INFORMATION FOR
THE USER
CRAMPEX TABLETS
nicotinic acid 20mg
calcium gluconate 200mg
cholecalciferol 0.02mg
READ ALL OF THIS LEAFLET CAREFULLY BECAUSE IT
CONTAINS IMPORTANT INFORMATION FOR YOU.
This medicine is available without prescription.
However, you still need to take Crampex Tablets
carefully to get the best results from it.
•● Keep this leaflet. You may need to read it
again.
•● Ask your pharmacist if you need any more
information or advice.
•● You must contact your doctor if your
symptoms worsen or do not improve.
•● If any of the side effects gets serious, or if
you notice any side effects not listed in this
leaflet, please tell your doctor or pharmacist.
IN THIS LEAFLET:
1. What Crampex Tablets are and what they are
used for
2. Before you take Crampex Tablets
3. How to take Crampex Tablets
4. Possible side effects
5. How to store Crampex Tablets
6. Further information
1. WHAT CRAMPEX TABLETS ARE
AND WHAT THEY ARE USED FOR
Crampex Tablets contain calcium gluconate and
cholecalciferol to increase calcium levels in the
blood as low levels of calcium can contribute to
muscle cramps. They also contain nicotinic acid
to improve circulation.
The tablets are for night time muscle cramp.
2. BEFORE YOU TAKE CRAMPEX
TABLETS
DO NOT TAKE THE MEDICINE IF YOU
HAVE….
•● An ALLERGY to any of the ingredients listed in
section 6.
•● An EXCESSIVE amount of CALCIUM IN YOUR
BLOOD.
TAKE SPECIAL CARE WITH CRAMPEX
TABLETS IF YOU HAVE….
•● Poor kidney function or have a tendency to
form kidney stones. Treatment with Crampex
should be kept as short as possible if this
applies.
•● High blood pressure.
•● Liver problems.
•● An ulcer in your digestive system (including
your stomach).
•● Diabetes.
•● Gout.
Talk to your doctor or pharmacist before taking
Crampex Tablets. TAKING OTHER MEDICINES….
Please tell your pharmacist if you are taking or
have recently taken any other medicines,
including medicines obtained without a
prescription.
•● If you are taking Dig
                                
                                Lue koko asiakirja
                                
                            

Valmisteyhteenveto

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Crampex Tablets
Cholecalciferol 0.02 mg
Calcium Gluconate 200 mg
Nicotinic Acid 20 mg
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
For a full list of excipients, see section 6.1
3 PHARMACEUTICAL FORM
Tablet
Flat, circular bevel-edged white tablets with the word ‘Crampex’
engraved on one face.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
For treatment of night muscle cramp.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
Oral.
Adults only (including elderly):
1 or 2 tablets before retiring.
Children:
Not recommended.
4.3 CONTRAINDICATIONS
Hypersensitivity to any of the ingredients.
Do not use in patients with hypercalcaemia.
Each tablet contains:
Colecalciferol
20
micrograms
Calcium Gluconate
200
mg
Nicotinic Acid
20
mg
H
E
A
L
T
H
P
R
O
D
U
C
T
S
R
E
G
U
L
A
T
O
R
Y
A
U
T
H
O
R
I
T
Y
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
___
_D_
_a_
_t_
_e_
_ _
_P_
_r_
_i_
_n_
_t_
_e_
_d_
_ _
_1_
_4_
_/_
_0_
_7_
_/_
_2_
_0_
_1_
_6_
_C_
_R_
_N_
_ _
_2_
_1_
_8_
_0_
_4_
_3_
_7_
_p_
_a_
_g_
_e_
_ _
_n_
_u_
_m_
_b_
_e_
_r_
_:_
_ _
_1_
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
Duration of treatment should be minimised in patients with impaired
renal function or a tendency to form kidney
stones.
Use with caution in patients with hypertension, a history of peptic
ulcer disease, diabetes mellitus, gout or impaired
liver function.
Not recommended for use in children.
Prolonged use is not recommended.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF
INTERACTION
Use with caution in patients taking digitalis.
4.6 FERTILITY, PREGNANCY 
                                
                                Lue koko asiakirja
                                
                            

Näytä asiakirjojen historia